Plasma enabled devices for the selective capture and photodynamic identification of prostate cancer cells
- 1 May 2020
- journal article
- research article
- Published by American Vacuum Society in Biointerphases
- Vol. 15 (3) , 031002
Abstract
Prostate cancer is the second most common cancer in men and the second leading cause of male cancer deaths. The current blood test for detecting prostate cancers measures prostate-specific antigen. It has many limitations including a very high rate of false positives. Herein, prostate-specific membrane antigen (PSMA) based immunocapture and hexaminolevulinate (HAL) based photodetection are integrated into a new diagnostic device designed to selectively identify whole prostate cancer cells from voided urine with the aim of providing an accurate noninvasive alternative to current diagnosis methods. Prestained, prostate cancer cells spiked in urine samples at concentrations ranging from 1500 to 2000 cells/ml were captured with 89% sensitivity and 95% specificity. HAL, a cancer specific photosensitizer, was then used to circumvent the need for prestaining. Optimum HAL incubation conditions were identified (50 μM at 37 °C for 2 h) where the mean HAL-induced fluorescence intensity of LNCaP cells was three times that of healthy PNT2 cells, thus providing an independent way to discriminate captured cancer cells from background metabolites. Combining anti-PSMA immunocapture with HAL-induced fluorescent detection, 86% sensitivity and 88% selectivity were achieved, thereby proving the validity of the dual-method for the selective photospecific detection of prostate cancer cells.Keywords
Funding Information
- Motherson Innovations Australia
- University of South Australia (Research Theme investment Scheme)
This publication has 36 references indexed in Scilit:
- Urinary biomarkers for prostate cancer: a reviewAsian Journal of Andrology, 2013
- PSMA as a target for radiolabelled small moleculesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2013
- Immunocapture of prostate cancer cells by use of anti-PSMA antibodies in microdevicesBiomedical Microdevices, 2011
- Specific detection of prostate cancer cells in urine by multiplex immunofluorescence cytologyHuman Pathology, 2009
- DNA methylation biomarkers of prostate cancer: Confirmation of candidates and evidence urine is the most sensitive body fluid for non‐invasive detectionThe Prostate, 2009
- Effects on Gram-Negative and Gram-Positive Bacteria Mediated by 5-Aminolevulinic Acid and 5-Aminolevulinic Acid DerivativesAntimicrobial Agents and Chemotherapy, 2008
- Targeted treatment of prostate cancerJournal of Cellular Biochemistry, 2007
- ALA induced photodynamic effects on Gram positive and negative bacteriaPhotochemical & Photobiological Sciences, 2004
- Hexyl Aminolevulinate Fluorescence Cystoscopy: A New Diagnostic Tool for Photodiagnosis of Superficial Bladder Cancer—A multicenter studyJournal of Urology, 2003
- Topical application of 5-aminolevulinic acid, DMSO and EDTA: protoporphyrin IX accumulation in skin and tumours of miceJournal of Photochemistry and Photobiology B: Biology, 1995